NYMOX PHARMACEUTICAL CORP's ticker is NYMX and the CUSIP is 67076P102. A total of 29 filers reported holding NYMOX PHARMACEUTICAL CORP in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2014 | $6,000 | -99.0% | 1,310 | -98.9% | 0.00% | -100.0% |
Q2 2014 | $599,000 | -9.2% | 120,913 | 0.0% | 0.00% | -33.3% |
Q1 2014 | $660,000 | -10.1% | 120,913 | 0.0% | 0.00% | 0.0% |
Q4 2013 | $734,000 | +42.2% | 120,913 | +55.2% | 0.00% | +50.0% |
Q3 2013 | $516,000 | – | 77,899 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MARATHON CAPITAL MANAGEMENT | 41,650 | $253,000 | 0.18% |
Eidelman Virant Capital | 27,796 | $169,000 | 0.07% |
WMS Partners, LLC | 63,350 | $384,000 | 0.06% |
SHEPHERD KAPLAN KROCHUK, LLC | 62,742 | $381,000 | 0.05% |
Brown Advisory Securities, LLC | 10,000 | $61,000 | 0.02% |
CROFT-LEOMINSTER INC | 20,000 | $121,000 | 0.02% |
GSA CAPITAL PARTNERS LLP | 15,479 | $94,000 | 0.01% |
GOFEN & GLOSSBERG LLC /IL/ | 25,000 | $152,000 | 0.01% |
CANADA PENSION PLAN INVESTMENT BOARD | 120,913 | $734,000 | 0.00% |
LADENBURG THALMANN FINANCIAL SERVICES INC. | 12,400 | $75,000 | 0.00% |